AI Bias Analysis
4 models · Takes ~15 seconds
(MedPage Today) -- FDA's independent advisors on Thursday endorsed the use of capivasertib (Truqap) for treating an aggressive subtype of prostate cancer. By a 7-1 vote, and with a single abstention, the Oncologic Drugs Advisory Committee agreed...
Source
MedPage Today
Opens original article in a new tab
(MedPage Today) -- You passed medical training, now see if you can pass our weekly quiz
(MedPage Today) -- The FDA has given the green light to an expanded access program (EAP) for the investigational pancreatic cancer drug daraxonrasib. In a "safe to proceed" letter to Revolution Medicines, the FDA gave its approval to initiate...
(MedPage Today) -- When the FDA announced recently that two drug companies had begun streaming clinical trial data to agency reviewers in real time, FDA Commissioner Marty Makary, MD, MPH, reached for an analogy from his own training. As a surgical...
(MedPage Today) -- The FDA approved oral vepdegestrant (Veppanu) for adults with advanced or metastatic estrogen receptor (ER)-positive/HER2-negative breast cancer, the agency announced on Friday. Approval of the first-in-class proteolysis targeting...
